Literature DB >> 19878064

Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity.

Remco Koninckx1, Karen Hensen, Annick Daniëls, Marjan Moreels, Ivo Lambrichts, Hanne Jongen, Christel Clijsters, Urbain Mees, Paul Steels, Marc Hendrikx, Jean-Luc Rummens.   

Abstract

BACKGROUND AIMS: This study investigated whether neonatal rat cardiomyocytes (NRCM), when co-cultured, can induce transdifferentiation of either human mesenchymal stromal cells (MSC) or hematopoietic stem cells (HSC) into cardiomyocytes. Stem cells were obtained from patients with ischemic heart disease.
METHODS: Ex vivo-expanded MSC or freshly isolated HSC were used to set-up a co-culture system between NRCM and MSC or HSC. 5-azacytidin (5-aza) or dimethylsulfoxide (DMSO) was used as differentiation-inducing factor. Co-cultured stem cells were separated from NRCM by flow sorting, and cardiac gene expression was analyzed by reverse transcriptase-polymerase chain reaction. Cellular morphology was analyzed by immunofluorescence and transmission electron microscopy (TEM).
RESULTS: Co-culturing MSC induced expression of troponin T and GATA-4. However, no expression of alpha-actinin, myosin heavy chain or troponin I was detected. In the case of HSC, only expression of troponin T could be induced. Immunofluorescence and TEM confirmed the absence of sarcomeric organization in co-cultured MSC and HSC. Adding 5-aza or DMSO to the co-cultures did not influence differentiation.
CONCLUSIONS: This in vitro co-culture study obtained no convincing evidence of transdifferentiation of either MSC or HSC into functional cardiomyocytes. Nevertheless, induction of troponin T was observed in MSC and HSC, and GATA-4 in MSC. However, no morphologic changes could be detected by immunofluorescence or by TEM. These data could explain why only limited functional improvement was reported in clinical stem cell trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878064     DOI: 10.3109/14653240902988818

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  19 in total

Review 1.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study.

Authors:  Remco Koninckx; Annick Daniëls; Severina Windmolders; Françoise Carlotti; Urbain Mees; Paul Steels; Jean-Luc Rummens; Marc Hendrikx; Karen Hensen
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

3.  Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.

Authors:  Georg Siegel; Petra Krause; Stefanie Wöhrle; Patrick Nowak; Miriam Ayturan; Torsten Kluba; Bernhard R Brehm; Birgid Neumeister; David Köhler; Peter Rosenberger; Lothar Just; Hinnak Northoff; Richard Schäfer
Journal:  Stem Cells Dev       Date:  2012-03-13       Impact factor: 3.272

4.  The mechanical coupling of adult marrow stromal stem cells during cardiac regeneration assessed in a 2-D co-culture model.

Authors:  Mani T Valarmathi; John W Fuseler; Richard L Goodwin; Jeffrey M Davis; Jay D Potts
Journal:  Biomaterials       Date:  2011-02-01       Impact factor: 12.479

5.  Clinical-scale in vitro expansion preserves biological characteristics of cardiac atrial appendage stem cells.

Authors:  S Windmolders; L Willems; A Daniëls; L Linsen; Y Fanton; M Hendrikx; R Koninckx; J-L Rummens; K Hensen
Journal:  Cell Prolif       Date:  2015-01-29       Impact factor: 6.831

6.  Transduction of Wnt11 promotes mesenchymal stem cell transdifferentiation into cardiac phenotypes.

Authors:  Zhisong He; Hongxia Li; Shi Zuo; Zeeshan Pasha; Yigang Wang; Yueting Yang; Wenping Jiang; Muhammad Ashraf; Meifeng Xu
Journal:  Stem Cells Dev       Date:  2011-02-26       Impact factor: 3.272

Review 7.  Human cardiomyogenesis and the need for systems biology analysis.

Authors:  D Adam Young; Jessica A DeQuach; Karen L Christman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

8.  Injection of mesenchymal stromal cells into a mechanically stimulated in vitro model of cardiac fibrosis has paracrine effects on resident fibroblasts.

Authors:  Peter A Galie; Jan P Stegemann
Journal:  Cytotherapy       Date:  2014-04-06       Impact factor: 5.414

9.  GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4.

Authors:  Hongxia Li; Shi Zuo; Zeeshan Pasha; Bin Yu; Zhisong He; Yigang Wang; Xiangjun Yang; Muhammad Ashraf; Meifeng Xu
Journal:  Cytotherapy       Date:  2011-08-17       Impact factor: 5.414

Review 10.  Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms.

Authors:  Timothy J Cashman; Valerie Gouon-Evans; Kevin D Costa
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.